Sun Pharmaceutical Industries is currently trading at Rs. 1728.50, up by 12.55 points or 0.73% from its previous closing of Rs. 1715.95 on the BSE.
The scrip opened at Rs. 1702.00 and has touched a high and low of Rs. 1730.65 and Rs. 1684.25 respectively. So far 87178 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1746.00 on 01-Aug-2024 and a 52 week low of Rs. 1069.00 on 31-Oct-2023.
Last one week high and low of the scrip stood at Rs. 1746.00 and Rs. 1681.95 respectively. The current market cap of the company is Rs. 412013.80 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.51% and 9.02% respectively.
Sun Pharmaceutical Industries has reported 37.52% fall in net profit at Rs 237.82 crore for first quarter ended June 30, 2024 as compared to Rs 380.64 crore for the same quarter in the previous year. Total income of the company decreased by 1.05% at Rs 4,580.81 crore for Q1FY25 as compared to Rs 4,629.61 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 40.20% rise in its net profit at Rs 2,835.62 crore for the quarter ended June 30, 2024 as compared to Rs 2,022.54 crore for the same quarter in the previous year. Total income of the company increased by 8.56% at Rs 13,185.30 crore for Q1FY25 as compared to Rs 12,145.28 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1744.35 |
Dr. Reddys Lab | 1200.90 |
Cipla | 1474.85 |
Lupin | 2011.25 |
Zydus Lifesciences | 950.55 |
View more.. |